2026年6月15日，基石药业-B（02616）于香港联交所发布翌日披露报表，公告公司于当日于场内回购6,000股普通股，占已发行股本约0.000004%。每股回购价格为4.66港元，合计动用资金27,960港元（折合约2.80万港元）。
公告显示，本次回购后，公司已发行股本于2026年6月15日仍为1,600,749,183股，库藏股维持0股。公司此前已于2025年6月25日通过购回授权，授权可回购股份总数为136,439,723股，本次回购占该授权通过日已发行股本的约0.00004%。
公司确认本次回购符合香港联交所证券上市规则及相关法律法规要求。公告由公司董事李伟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.